Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Hepatitis C Testing Proposed for All Baby Boomers

By LabMedica International staff writers
Posted on 05 Jun 2012
Expanded hepatitis C virus (HCV) testing has been proposed calling for all baby boomers in the US, individuals born from 1945 through 1965, to get a one-time test for the virus.

The proposed new recommendations could identify an additional 800,000 people living with HCV infection and prevent more than 120,000 HCV-related deaths during the current baby boomer cohort lifespan.

According to the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA), HCV can go undetected for decades and is the most common reason for liver transplantation and the leading cause of liver cancer, which is the fastest-rising cause of cancer-related deaths in the US. More...
More than 15,000 Americans die each year from HCV-related illness, including cirrhosis and liver cancer.

More than 75% of American adults infected with HCV are baby boomers, representing an estimated 2.1 million people. In addition, baby boomers are five times more likely to be infected with HCV than other American adults are. The CDC states that approximately 1 in 30 baby boomers has been infected with the virus, but most do not know it. The new guidelines, which also call for all baby boomers diagnosed with HCV infection to be linked to care and treatment, expand the existing, risk-based testing guidelines. HCV ribonucleic acid (RNA) qualitative test may be used to distinguish between a current or past infection and the HCV Viral Load quantitative test detects and measures the number of viral RNA particles in the blood.

John W. Ward, MD, Director of the Division of Viral Hepatitis at CDC, said, "Most baby boomers were infected when they were in their teens or twenties. Some may have been infected through receiving transfusions before the development of modern blood screening procedures in 1992, or experimentation with injection drugs." Dr. Ward added, "Because these exposures were often so long ago, many baby boomers may not even remember the events that could have placed them at risk, and many healthcare providers are reluctant to ask patients about past behaviors. As a result, many baby boomers have not been tested for hepatitis C."

Related Links:

US Centers for Disease Control and Prevention




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.